Sandra Levy
ARTICLES BY THIS AUTHOR
- 11/11/2019
Diplomat posts Q3 loss along with drop in PBM segment
Diplomat's Q3 revenue was comprised of $1.2 billion from the company’s specialty segment and $82 million from its pharmacy benefit manager segment - 11/11/2019
Breckenridge gets FDA green light for generic Tarceva
Tarceva and its generics had a market value of approximately $145 million during the year ended Sept, 30, 2019. - 11/11/2019
Bartell Drugs launches Instacart delivery
Bartell's, which introduced NimbleRx for prescription delivery early this year, is launching Instacart. - 11/10/2019
Rite Aid Foundation donates $75K to California wildfire relief efforts
The Rite Aid Foundation's $75,000 donation to the American Red Cross will be divided to help relief efforts in Northern and Southern California. - 11/10/2019
Foamix, Menlo Therapeutics to merge
Foamix and Menlo’s merger will result in a combined company focused on the dermatology space. - 11/10/2019
KKR reportedly approaches Walgreens Boots Alliance on leveraged buyout
Private equity firm KKR has reportedly been preparing a proposal to take Walgreens Boots Alliance private. - 11/10/2019
Glenmark gets FDA nod for generic Epiduo
Epiduo gel had a market value of about $33.7 million for the 12 month period ended September 2019, according to IQVIA. - 11/7/2019
CVS to close 22 underperforming stores in first quarter 2020
In an SEC filing on Nov. 6, CVS signaled its intention to close 22 underperforming retail pharmacy stores in the first quarter of 2020. - 11/7/2019
Fresenius Kabi launches small-volume prefilled heparin sodium syringes
Fresenius Kabi is expanding its heparin and Simplist prefilled syringe portfolio with the addition of a small-volume presentation of Heparin. - 11/7/2019
Celgene gets FDA green light for Reblozyl
Celgene’s Reblozyl is the first therapy to treat patients with a rare blood disorder.
